Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Clinical Roundup

Study finds AI blood test developed at Johns Hopkins successfully detects liver cancer

November 18, 2022
Vol.48 No.42
Clinical Roundup

Hopkins AI system helps predict patient response to cancer immunotherapy

November 18, 2022
Vol.48 No.42
Clinical Roundup

Sylvester researchers develop automated system to calculate metabolic tumor volume in DLBCL

November 18, 2022
Vol.48 No.42
Drugs & Targets

MD Anderson, Exscientia collaborate to develop oncology treatments using AI

November 18, 2022
Vol.48 No.42
In Brief

LSU Health New Orleans and ConcertAI form multi-year collaboration addressing diversity in clinical trials

September 30, 2022
Vol.48 No.35
In Brief

UCSD to lead components of NIH Common Fund’s Bridge to Artificial Intelligence program

September 23, 2022
Vol.48 No.34
Drugs & Targets

Indivumed and CELLphenomics form partnership for improved patient care in EU-funded project

September 16, 2022
Vol.48 No.33
Drugs & Targets

C2i Genomics, Karkinos Healthcare partner to bring AI-powered cancer R&D to India

June 03, 2022
Vol.48 No.22
Drugs & Targets

Case Western, Picture Health partner to develop AI tools for lung cancer

May 27, 2022
Vol.48 No.21
Clinical Roundup

GIST researchers develop deep learning model to predict adverse drug-drug interactions

May 06, 2022
Vol.48 No.18

Posts navigation

Previous1…1516

Trending Stories

  • “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
    In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process
  • DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
  • FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
    “Patients are owed another review.”
  • How City of Hope is turning microbiome science into better cancer care
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • FDA clears fruit-flavored vapes, relaxes enforcement on black-market products with pending premarket applications
    Critics say policies clear the way for major tobacco companies to enter fruit-flavored vape market

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account